CENTRAL NERVOUS SYSTEM LYMPHOMA
Clinical trials for CENTRAL NERVOUS SYSTEM LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new CENTRAL NERVOUS SYSTEM LYMPHOMA trials appear
Sign up with your email to follow new studies for CENTRAL NERVOUS SYSTEM LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Brain cancer trial tests aggressive chemo vs. stem cell transplant
Disease control CompletedThis study tested different combinations of chemotherapy drugs, with or without a targeted antibody drug, for adults newly diagnosed with lymphoma that starts in the brain or spinal cord. After initial chemo, patients who responded well were randomly assigned to receive either ra…
Matched conditions: CENTRAL NERVOUS SYSTEM LYMPHOMA
Phase: PHASE2 • Sponsor: International Extranodal Lymphoma Study Group (IELSG) • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Your genes could predict your reaction to a cancer drug
Knowledge-focused CompletedThis study aimed to understand how a person's genetic makeup affects how quickly their body processes a high-dose chemotherapy drug called methotrexate, which is used to treat certain lymphomas. Researchers studied 20 adult patients to see if specific gene variations were linked …
Matched conditions: CENTRAL NERVOUS SYSTEM LYMPHOMA
Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:29 UTC